scispace - formally typeset
S

Shuxin Sun

Researcher at Sun Yat-sen University

Publications -  21
Citations -  270

Shuxin Sun is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Irreversible electroporation & Cancer. The author has an hindex of 5, co-authored 18 publications receiving 120 citations.

Papers
More filters
Journal ArticleDOI

Immunomodulatory Effect after Irreversible Electroporation in Patients with Locally Advanced Pancreatic Cancer

TL;DR: The alteration of CD8+ T cell between D3 and D7 showed relatively good performance and could be used as an effective tool for prognostic evaluation for LAPC patients after IRE, the first evidence of IRE-based immunomodulatory in patients with LapC.
Journal ArticleDOI

Oxidative stress induces monocyte-to-myofibroblast transdifferentiation through p38 in pancreatic ductal adenocarcinoma.

TL;DR: Oxidative stress in the tumor microenvironment could induce MMT in PDAC, thus inducing reactive stroma, modulating immunosuppression, and promoting tumor progression, and reducing oxidative stress may be a promising future therapeutic regimen.
Journal ArticleDOI

Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity score analysis

TL;DR: Induction chemotherapy followed by IRE is superior to induction chemotherapy following by radiotherapy for treating LAPC and a randomized clinical trial comparing the efficacy of IRE and radiotherapy after the induction chemotherapy is considerable.
Journal ArticleDOI

The role of irreversible electroporation in promoting M1 macrophage polarization via regulating the HMGB1-RAGE-MAPK axis in pancreatic cancer.

TL;DR: In this paper, reversible electroporation was used to induce macrophage polarization induced by activating the MAPK-p38 pathway and increasing the expression of M1 markers in macrophages, through binding to the advanced glycation endproduct (RAGE) receptor.
Journal ArticleDOI

Combining NanoKnife with M1 oncolytic virus enhances anticancer activity in pancreatic cancer.

TL;DR: It was shown that IRE triggered reactive oxygen species (ROS)-dependent apoptosis in pancreatic cancer cells (PCCs) mediated by phosphatidylinositol-3-kinase (PI3K)/protein kinase B (Akt) pathway suppression and when NanoKnife was combined with M1 virus, the therapeutic efficacy was synergistically enhanced.